Global Antidepressants Market By Drug Class (Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Serotonin Antagonist, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, and Others), By Indication (Major Depressive Disorder, Attention Deficit Hyperactivity Disorder, Anxiety Disorders, and Others), By Route of Administration (Oral and Injectable), By End-User (Hospitals & Specialty Centres and Homecare), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2033

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Antidepressants Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Antidepressants Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Antidepressants Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 3.3. Global Antidepressants Market Attractiveness Analysis, By Drug Class
    • 3.3.1. Selective Serotonin Reuptake Inhibitors
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Reuptake Inhibitors
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Serotonin-Norepinephrine Reuptake Inhibitors
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
    • 3.3.4. Tricyclic Antidepressants
      • 3.3.4.1. Insights
      • 3.3.4.2. Key Takeaways
    • 3.3.5. Serotonin Antagonist
      • 3.3.5.1. Insights
      • 3.3.5.2. Key Takeaways
    • 3.3.6. Monoamine Oxidase Inhibitors
      • 3.3.6.1. Insights
      • 3.3.6.2. Key Takeaways
    • 3.3.7. Others
      • 3.3.7.1. Insights
      • 3.3.7.2. Key Takeaways
  • 3.4. Global Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 3.5. Global Antidepressants Market Attractiveness Analysis, By Indication
    • 3.5.1. Major Depressive Disorder
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Attention Deficit Hyperactivity Disorder
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Anxiety Disorders
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Others
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
  • 3.6. Global Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 3.7. Global Antidepressants Market Attractiveness Analysis, By Route of Administration
    • 3.7.1. Oral
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Injectable
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
  • 3.8. Global Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 3.9. Global Antidepressants Market Attractiveness Analysis, By End-user
    • 3.9.1. Hospitals & Specialty Centres
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Homecare
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
• 4. Global Antidepressants Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Antidepressants Market Attractiveness Analysis, By Region
• 5. North America Antidepressants Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 5.3. North America Antidepressants Market Attractiveness Analysis, By Drug Class
  • 5.4. North America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 5.5. North America Antidepressants Market Attractiveness Analysis, By Indication
  • 5.6. North America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 5.7. North America Antidepressants Market Attractiveness Analysis, By Route of Administration
  • 5.8. North America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 5.9. North America Antidepressants Market Attractiveness Analysis, By End-user
  • 5.10. North America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.11. North America Antidepressants Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Antidepressants Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 6.3. Europe Antidepressants Market Attractiveness Analysis, By Drug Class
  • 6.4. Europe Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 6.5. Europe Antidepressants Market Attractiveness Analysis, By Indication
  • 6.6. Europe Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 6.7. Europe Antidepressants Market Attractiveness Analysis, By Route of Administration
  • 6.8. Europe Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 6.9. Europe Antidepressants Market Attractiveness Analysis, By End-user
  • 6.10. Europe Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.11. Europe Antidepressants Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Antidepressants Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 7.3. Asia Pacific Antidepressants Market Attractiveness Analysis, By Drug Class
  • 7.4. Asia Pacific Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 7.5. Asia Pacific Antidepressants Market Attractiveness Analysis, By Indication
  • 7.6. Asia Pacific Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 7.7. Asia Pacific Antidepressants Market Attractiveness Analysis, By Route of Administration
  • 7.8. Asia Pacific Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 7.9. Asia Pacific Antidepressants Market Attractiveness Analysis, By End-user
  • 7.10. Asia Pacific Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.11. Asia Pacific Antidepressants Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Antidepressants Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 8.3. Latin America Antidepressants Market Attractiveness Analysis, By Drug Class
  • 8.4. Latin America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 8.5. Latin America Antidepressants Market Attractiveness Analysis, By Indication
  • 8.6. Latin America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 8.7. Latin America Antidepressants Market Attractiveness Analysis, By Route of Administration
  • 8.8. Latin America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 8.9. Latin America Antidepressants Market Attractiveness Analysis, By End-user
  • 8.10. Latin America Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.11. Latin America Antidepressants Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Antidepressants Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  • 9.3. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Drug Class
  • 9.4. Middle East & Africa Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2020-2034
  • 9.5. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Indication
  • 9.6. Middle East & Africa Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 9.7. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Route of Administration
  • 9.8. Middle East & Africa Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 9.9. Middle East & Africa Antidepressants Market Attractiveness Analysis, By End-user
  • 9.10. Middle East & Africa Antidepressants Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.11. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Mallinckrodt
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Johnson & Johnson
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. GlaxoSmithKline plc.
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Endo Pharmaceuticals plc
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Lundbeck
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Avet Pharmaceuticals Inc.
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Aurobindo Pharma
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Sun Pharmaceutical Industries Limited
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 2. Global Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 3. Global Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 4. Global Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 5. Global Antidepressants Market Value (US$ Mn), By Region, 2020-2034
• Table 6. North America Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 7. North America Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 8. North America Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 9. North America Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 10. North America Antidepressants Market Value (US$ Mn), By Country, 2020-2034
• Table 11. The US Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 12. The US Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 13. The US Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 14. The US Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 15. Canada Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 16. Canada Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 17. Canada Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 18. Canada Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 19. Europe Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 20. Europe Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 21. Europe Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 22. Europe Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 23. Europe Antidepressants Market Value (US$ Mn), By Country, 2020-2034
• Table 24. Germany Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 25. Germany Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 26. Germany Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 27. Germany Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 28. The UK Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 29. The UK Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 30. The UK Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 31. The UK Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 32. France Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 33. France Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 34. France Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 35. France Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 36. Spain Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 37. Spain Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 38. Spain Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 39. Spain Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 40. Italy Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 41. Italy Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 42. Italy Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 43. Italy Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 44. Russia Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 45. Russia Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 46. Russia Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 47. Russia Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 48. Netherland Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 49. Netherland Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 50. Netherland Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 51. Netherland Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 52. Rest of Europe Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 53. Rest of Europe Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 54. Rest of Europe Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 55. Rest of Europe Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 56. Asia Pacific Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 57. Asia Pacific Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 58. Asia Pacific Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 59. Asia Pacific Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 60. Asia Pacific Antidepressants Market Value (US$ Mn), By Country, 2020-2034
• Table 61. China Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 62. China Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 63. China Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 64. China Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 65. India Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 66. India Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 67. India Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 68. India Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 69. Japan Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 70. Japan Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 71. Japan Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 72. Japan Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 73. South Korea Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 74. South Korea Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 75. South Korea Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 76. South Korea Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 77. Australia Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 78. Australia Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 79. Australia Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 80. Australia Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 81. New Zealand Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 82. New Zealand Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 83. New Zealand Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 84. New Zealand Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 85. Singapore Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 86. Singapore Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 87. Singapore Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 88. Singapore Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 89. Thailand Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 90. Thailand Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 91. Thailand Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 92. Thailand Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 93. Vietnam Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 94. Vietnam Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 95. Vietnam Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 96. Vietnam Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 97. Rest of Asia Pacific Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 98. Rest of Asia Pacific Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 99. Rest of Asia Pacific Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 100. Rest of Asia Pacific Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 101. Latin America Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 102. Latin America Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 103. Latin America Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 104. Latin America Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 105. Latin America Antidepressants Market Value (US$ Mn), By Country, 2020-2034
• Table 106. Brazil Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 107. Brazil Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 108. Brazil Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 109. Brazil Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 110. Mexico Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 111. Mexico Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 112. Mexico Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 113. Mexico Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 114. Rest of Latin America Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 115. Rest of Latin America Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 116. Rest of Latin America Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 117. Rest of Latin America Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 118. Middle East & Africa Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 119. Middle East & Africa Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 120. Middle East & Africa Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 121. Middle East & Africa Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 122. Middle East & Africa Antidepressants Market Value (US$ Mn), By Country, 2020-2034
• Table 123. South Africa Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 124. South Africa Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 125. South Africa Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 126. South Africa Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 127. Saudi Arabia Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 128. Saudi Arabia Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 129. Saudi Arabia Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 130. Saudi Arabia Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 131. UAE Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 132. UAE Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 133. UAE Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 134. UAE Antidepressants Market Value (US$ Mn), By End-user, 2020-2034
• Table 135. Rest of Middle East & Africa Antidepressants Market Value (US$ Mn), By Drug Class, 2020-2034
• Table 136. Rest of Middle East & Africa Antidepressants Market Value (US$ Mn), By Indication, 2020-2034
• Table 137. Rest of Middle East & Africa Antidepressants Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 138. Rest of Middle East & Africa Antidepressants Market Value (US$ Mn), By End-user, 2020-2034

List of Figures

• Figure 1. Global Antidepressants Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Antidepressants Market
• Figure 5. Global Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 6. Global Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 7. Global Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 8. Global Antidepressants Market Attractiveness Analysis, By Indication
• Figure 9. Global Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 10. Global Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 11. Global Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 12. Global Antidepressants Market Attractiveness Analysis, By End-user
• Figure 13. Global Antidepressants Market Analysis, By Region, 2020, 2024 and 2034
• Figure 14. Global Antidepressants Market Attractiveness Analysis, By Region
• Figure 15. North America Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 16. North America Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 17. North America Antidepressants Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2020-2034
• Figure 18. North America Antidepressants Market (US$ Mn), by Reuptake Inhibitors, 2020-2034
• Figure 19. North America Antidepressants Market (US$ Mn), by Serotonin-Norepinephrine Reuptake Inhibitors, 2020-2034
• Figure 20. North America Antidepressants Market (US$ Mn), by Tricyclic Antidepressants, 2020-2034
• Figure 21. North America Antidepressants Market (US$ Mn), by Serotonin Antagonist, 2020-2034
• Figure 22. North America Antidepressants Market (US$ Mn), by Monoamine Oxidase Inhibitors, 2020-2034
• Figure 23. North America Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 24. North America Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 25. North America Antidepressants Market Attractiveness Analysis, By Indication
• Figure 26. North America Antidepressants Market (US$ Mn), by Major Depressive Disorder, 2020-2034
• Figure 27. North America Antidepressants Market (US$ Mn), by Attention Deficit Hyperactivity Disorder, 2020-2034
• Figure 28. North America Antidepressants Market (US$ Mn), by Anxiety Disorders, 2020-2034
• Figure 29. North America Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 30. North America Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 31. North America Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 32. North America Antidepressants Market (US$ Mn), by Oral, 2020-2034
• Figure 33. North America Antidepressants Market (US$ Mn), by Injectable, 2020-2034
• Figure 34. North America Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 35. North America Antidepressants Market Attractiveness Analysis, By End-user
• Figure 36. North America Antidepressants Market (US$ Mn), by Hospitals & Specialty Centres, 2020-2034
• Figure 37. North America Antidepressants Market (US$ Mn), by Homecare, 2020-2034
• Figure 38. North America Antidepressants Market Analysis, By Country, 2020, 2024 and 2034
• Figure 39. North America Antidepressants Market Attractiveness Analysis, By Country
• Figure 40. Europe Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 41. Europe Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 42. Europe Antidepressants Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2020-2034
• Figure 43. Europe Antidepressants Market (US$ Mn), by Reuptake Inhibitors, 2020-2034
• Figure 44. Europe Antidepressants Market (US$ Mn), by Serotonin-Norepinephrine Reuptake Inhibitors, 2020-2034
• Figure 45. Europe Antidepressants Market (US$ Mn), by Tricyclic Antidepressants, 2020-2034
• Figure 46. Europe Antidepressants Market (US$ Mn), by Serotonin Antagonist, 2020-2034
• Figure 47. Europe Antidepressants Market (US$ Mn), by Monoamine Oxidase Inhibitors, 2020-2034
• Figure 48. Europe Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 49. Europe Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 50. Europe Antidepressants Market Attractiveness Analysis, By Indication
• Figure 51. Europe Antidepressants Market (US$ Mn), by Major Depressive Disorder, 2020-2034
• Figure 52. Europe Antidepressants Market (US$ Mn), by Attention Deficit Hyperactivity Disorder, 2020-2034
• Figure 53. Europe Antidepressants Market (US$ Mn), by Anxiety Disorders, 2020-2034
• Figure 54. Europe Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 55. Europe Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 56. Europe Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 57. Europe Antidepressants Market (US$ Mn), by Oral, 2020-2034
• Figure 58. Europe Antidepressants Market (US$ Mn), by Injectable, 2020-2034
• Figure 59. Europe Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 60. Europe Antidepressants Market Attractiveness Analysis, By End-user
• Figure 61. Europe Antidepressants Market (US$ Mn), by Hospitals & Specialty Centres, 2020-2034
• Figure 62. Europe Antidepressants Market (US$ Mn), by Homecare, 2020-2034
• Figure 63. Europe Antidepressants Market Analysis, By Country, 2020, 2024 and 2034
• Figure 64. Europe Antidepressants Market Attractiveness Analysis, By Country
• Figure 65. Asia Pacific Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 66. Asia Pacific Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 67. Asia Pacific Antidepressants Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2020-2034
• Figure 68. Asia Pacific Antidepressants Market (US$ Mn), by Reuptake Inhibitors, 2020-2034
• Figure 69. Asia Pacific Antidepressants Market (US$ Mn), by Serotonin-Norepinephrine Reuptake Inhibitors, 2020-2034
• Figure 70. Asia Pacific Antidepressants Market (US$ Mn), by Tricyclic Antidepressants, 2020-2034
• Figure 71. Asia Pacific Antidepressants Market (US$ Mn), by Serotonin Antagonist, 2020-2034
• Figure 72. Asia Pacific Antidepressants Market (US$ Mn), by Monoamine Oxidase Inhibitors, 2020-2034
• Figure 73. Asia Pacific Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 74. Asia Pacific Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 75. Asia Pacific Antidepressants Market Attractiveness Analysis, By Indication
• Figure 76. Asia Pacific Antidepressants Market (US$ Mn), by Major Depressive Disorder, 2020-2034
• Figure 77. Asia Pacific Antidepressants Market (US$ Mn), by Attention Deficit Hyperactivity Disorder, 2020-2034
• Figure 78. Asia Pacific Antidepressants Market (US$ Mn), by Anxiety Disorders, 2020-2034
• Figure 79. Asia Pacific Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 80. Asia Pacific Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 81. Asia Pacific Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 82. Asia Pacific Antidepressants Market (US$ Mn), by Oral, 2020-2034
• Figure 83. Asia Pacific Antidepressants Market (US$ Mn), by Injectable, 2020-2034
• Figure 84. Asia Pacific Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 85. Asia Pacific Antidepressants Market Attractiveness Analysis, By End-user
• Figure 86. Asia Pacific Antidepressants Market (US$ Mn), by Hospitals & Specialty Centres, 2020-2034
• Figure 87. Asia Pacific Antidepressants Market (US$ Mn), by Homecare, 2020-2034
• Figure 88. Asia Pacific Antidepressants Market Analysis, By Country, 2020, 2024 and 2034
• Figure 89. Asia Pacific Antidepressants Market Attractiveness Analysis, By Country
• Figure 90. Latin America Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 91. Latin America Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 92. Latin America Antidepressants Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2020-2034
• Figure 93. Latin America Antidepressants Market (US$ Mn), by Reuptake Inhibitors, 2020-2034
• Figure 94. Latin America Antidepressants Market (US$ Mn), by Serotonin-Norepinephrine Reuptake Inhibitors, 2020-2034
• Figure 95. Latin America Antidepressants Market (US$ Mn), by Tricyclic Antidepressants, 2020-2034
• Figure 96. Latin America Antidepressants Market (US$ Mn), by Serotonin Antagonist, 2020-2034
• Figure 97. Latin America Antidepressants Market (US$ Mn), by Monoamine Oxidase Inhibitors, 2020-2034
• Figure 98. Latin America Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 99. Latin America Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 100. Latin America Antidepressants Market Attractiveness Analysis, By Indication
• Figure 101. Latin America Antidepressants Market (US$ Mn), by Major Depressive Disorder, 2020-2034
• Figure 102. Latin America Antidepressants Market (US$ Mn), by Attention Deficit Hyperactivity Disorder, 2020-2034
• Figure 103. Latin America Antidepressants Market (US$ Mn), by Anxiety Disorders, 2020-2034
• Figure 104. Latin America Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 105. Latin America Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 106. Latin America Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 107. Latin America Antidepressants Market (US$ Mn), by Oral, 2020-2034
• Figure 108. Latin America Antidepressants Market (US$ Mn), by Injectable, 2020-2034
• Figure 109. Latin America Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 110. Latin America Antidepressants Market Attractiveness Analysis, By End-user
• Figure 111. Latin America Antidepressants Market (US$ Mn), by Hospitals & Specialty Centres, 2020-2034
• Figure 112. Latin America Antidepressants Market (US$ Mn), by Homecare, 2020-2034
• Figure 113. Latin America Antidepressants Market Analysis, By Country, 2020, 2024 and 2034
• Figure 114. Latin America Antidepressants Market Attractiveness Analysis, By Country
• Figure 115. Middle East & Africa Antidepressants Market Analysis, By Drug Class, 2020, 2024 and 2034
• Figure 116. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Drug Class
• Figure 117. Middle East & Africa Antidepressants Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2020-2034
• Figure 118. Middle East & Africa Antidepressants Market (US$ Mn), by Reuptake Inhibitors, 2020-2034
• Figure 119. Middle East & Africa Antidepressants Market (US$ Mn), by Serotonin-Norepinephrine Reuptake Inhibitors, 2020-2034
• Figure 120. Middle East & Africa Antidepressants Market (US$ Mn), by Tricyclic Antidepressants, 2020-2034
• Figure 121. Middle East & Africa Antidepressants Market (US$ Mn), by Serotonin Antagonist, 2020-2034
• Figure 122. Middle East & Africa Antidepressants Market (US$ Mn), by Monoamine Oxidase Inhibitors, 2020-2034
• Figure 123. Middle East & Africa Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 124. Middle East & Africa Antidepressants Market Analysis, By Indication, 2020, 2024 and 2034
• Figure 125. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Indication
• Figure 126. Middle East & Africa Antidepressants Market (US$ Mn), by Major Depressive Disorder, 2020-2034
• Figure 127. Middle East & Africa Antidepressants Market (US$ Mn), by Attention Deficit Hyperactivity Disorder, 2020-2034
• Figure 128. Middle East & Africa Antidepressants Market (US$ Mn), by Anxiety Disorders, 2020-2034
• Figure 129. Middle East & Africa Antidepressants Market (US$ Mn), by Others, 2020-2034
• Figure 130. Middle East & Africa Antidepressants Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 131. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Route of Administration
• Figure 132. Middle East & Africa Antidepressants Market (US$ Mn), by Oral, 2020-2034
• Figure 133. Middle East & Africa Antidepressants Market (US$ Mn), by Injectable, 2020-2034
• Figure 134. Middle East & Africa Antidepressants Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 135. Middle East & Africa Antidepressants Market Attractiveness Analysis, By End-user
• Figure 136. Middle East & Africa Antidepressants Market (US$ Mn), by Hospitals & Specialty Centres, 2020-2034
• Figure 137. Middle East & Africa Antidepressants Market (US$ Mn), by Homecare, 2020-2034
• Figure 138. Middle East & Africa Antidepressants Market Analysis, By Country, 2020, 2024 and 2034
• Figure 139. Middle East & Africa Antidepressants Market Attractiveness Analysis, By Country